Yilmaz, M. Et Al. 2005. The effects of rosiglitazone and metformin on insulin resistance and serum androgen levels in obese and lean patients with polycystic ovary syndrome. JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION , vol.28, no.11 , 1003-1008.

Yilmaz, M., Biri, A., Karakoc, A., Toruner, F., Bingol, B., Cakir, N., ... Tiras, B.(2005). The effects of rosiglitazone and metformin on insulin resistance and serum androgen levels in obese and lean patients with polycystic ovary syndrome. JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION , vol.28, no.11, 1003-1008.

Yilmaz, M Et Al. "The effects of rosiglitazone and metformin on insulin resistance and serum androgen levels in obese and lean patients with polycystic ovary syndrome," JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION , vol.28, no.11, 1003-1008, 2005

Yilmaz, M Et Al. "The effects of rosiglitazone and metformin on insulin resistance and serum androgen levels in obese and lean patients with polycystic ovary syndrome." JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION , vol.28, no.11, pp.1003-1008, 2005

Yilmaz, M. Et Al. (2005) . "The effects of rosiglitazone and metformin on insulin resistance and serum androgen levels in obese and lean patients with polycystic ovary syndrome." JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION , vol.28, no.11, pp.1003-1008.

@article{article, author={M Yilmaz Et Al. }, title={The effects of rosiglitazone and metformin on insulin resistance and serum androgen levels in obese and lean patients with polycystic ovary syndrome}, journal={JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION}, year=2005, pages={1003-1008} }